State Street Corp Amicus Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 10,970,746 shares of FOLD stock, worth $105 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,970,746

Previous 11,016,963 0.42%

Holding current value

$105 Million

Previous $109 Million 7.21%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$9.55 - $12.09 $441,372 - $558,763	-46,217 Reduced 0.42%	10,970,746 $117 Million
Q2 2024 Aug 14, 2024	SELL	$9.04 - $11.75 $12.9 Million - $16.8 Million	-1,425,538 Reduced 11.46%	11,016,963 $109 Million
Q1 2024 May 15, 2024	SELL	$11.43 - $14.24 $8.24 Million - $10.3 Million	-720,584 Reduced 5.47%	12,442,501 $147 Million
Q4 2023 Feb 14, 2024	BUY	$9.97 - $14.52 $17.9 Million - $26 Million	1,790,649 Added 15.75%	13,163,085 $187 Million
Q3 2023 Nov 14, 2023	BUY	$11.78 - $13.86 $2.28 Million - $2.68 Million	193,194 Added 1.73%	11,372,436 $138 Million
Q2 2023 Aug 14, 2023	BUY	$10.72 - $13.3 $518,387 - $643,148	48,357 Added 0.43%	11,179,242 $140 Million
Q1 2023 May 15, 2023	SELL	$10.91 - $13.54 $10.4 Million - $12.9 Million	-954,954 Reduced 7.9%	11,130,885 $123 Million
Q4 2022 Feb 14, 2023	BUY	$9.89 - $12.7 $629,271 - $808,062	63,627 Added 0.53%	12,085,839 $148 Million
Q3 2022 Nov 15, 2022	SELL	$9.82 - $12.75 $18.6 Million - $24.2 Million	-1,896,103 Reduced 13.62%	12,022,212 $126 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $11.12 $12.4 Million - $22.1 Million	1,983,752 Added 16.62%	13,918,315 $149 Million
Q1 2022 May 16, 2022	BUY	$7.89 - $12.48 $11.3 Million - $17.9 Million	1,432,498 Added 13.64%	11,934,563 $113 Million
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $4.78 Million - $6.05 Million	486,335 Added 4.86%	10,502,065 $121 Million
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $5.06 Million - $6.86 Million	579,481 Added 6.14%	10,015,730 $95.7 Million
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $877,036 - $1.08 Million	-100,693 Reduced 1.06%	9,436,249 $91 Million
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $15 Million - $38.8 Million	1,627,551 Added 20.58%	9,536,942 $94.2 Million
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $13.7 Million - $25.4 Million	-1,019,668 Reduced 11.42%	7,909,391 $183 Million
Q3 2020 Nov 10, 2020	SELL	$12.89 - $15.89 $17.5 Million - $21.5 Million	-1,354,448 Reduced 13.17%	8,929,059 $126 Million
Q2 2020 Aug 14, 2020	SELL	$8.86 - $15.69 $7.49 Million - $13.3 Million	-845,644 Reduced 7.6%	10,283,507 $155 Million
Q1 2020 May 11, 2020	BUY	$6.63 - $11.16 $73.8 Million - $124 Million	11,129,151 New	11,129,151 $103 Million

Others Institutions Holding FOLD

# of Institutions

313

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.69B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Amicus Therapeutics, Inc. Transaction History